Cargando…
Identification of surrogate endpoints in patients with locoregionally advanced nasopharyngeal carcinoma receiving neoadjuvant chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone
BACKGROUND: In the era of intensity-modulated radiotherapy (IMRT), the efficacy of additional neoadjuvant chemotherapy (NACT) to concurrent chemoradiotherapy (CCRT) in locoregionally advanced nasopharyngeal carcinoma (NPC) is currently being investigated in ongoing trials. Overall survival (OS) is t...
Autores principales: | Chen, Yu-Pei, Zhang, Wen-Na, Tang, Ling-Long, Mao, Yan-Ping, Liu, Xu, Chen, Lei, Zhou, Guan-Qun, Mai, Hai-Qiang, Shao, Jian-Yong, Jia, Wei-Hua, Kang, Tie-Bang, Zeng, Mu-Sheng, Sun, Ying, Ma, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4659203/ https://www.ncbi.nlm.nih.gov/pubmed/26603423 http://dx.doi.org/10.1186/s12885-015-1816-6 |
Ejemplares similares
-
Induction Chemotherapy Plus Concurrent Chemoradiotherapy Versus Concurrent Chemoradiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma in Children and Adolescents: A Matched Cohort Analysis
por: Li, Yang, et al.
Publicado: (2018) -
Comparison of Induction Chemotherapy Plus Concurrent
Chemoradiotherapy and Concurrent Chemoradiotherapy Alone in Locally Advanced
Nasopharyngeal Carcinoma
por: Xu, Guoqiang, et al.
Publicado: (2021) -
Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in nasopharyngeal carcinoma patients with cervical nodal necrosis
por: Lan, Mei, et al.
Publicado: (2017) -
Efficacy and safety of nimotuzumab with neoadjuvant chemotherapy followed by concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma
por: Wang, Fangzheng, et al.
Publicado: (2017) -
Concurrent chemoradiotherapy plus anlotinib vs. concurrent chemoradiotherapy alone in locally advanced nasopharyngeal carcinoma: An interim analysis of a multicenter randomized controlled trial
por: Chen, Kequan, et al.
Publicado: (2023)